Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-06-11

Clinical Trial Update: Bacteriophage Therapy for Methicillin-Sensitive Staphylococcus Aureus Prosthetic Joint Infection [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update describes a bacteriophage therapy being evaluated for methicillin-susceptible Staphylococcus aureus prosthetic joint infection in Phase …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bacteriophage therapy

Snippet

Sponsor: University of Calgary | Conditions: Prosthetic Joint Infections of Hip, Staphylococcus Aureus Infection | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING